Newsletter Subject

Novel Drug Reduced Triglycerides, Risk of Pancreatitis in Persistent Chylomicronemia

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Sep 3, 2024 10:43 PM

Email Preheader Text

Daily Headlines Tuesday, September 03, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLI

[MEDPAGE TODAY]( Daily Headlines Tuesday, September 03, 2024 Today's Top Stories for {NAME} [MEETING COVERAGE]( [Novel Drug Reduced Triglycerides, Risk of Pancreatitis in Persistent Chylomicronemia]( [NEUROLOGY]( [Brain Aging Trajectories Identified in Post-Mortem Tissue]( [PERSPECTIVES]( [Neffy Is About to Hit Shelves: Considerations for Prescribing]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Navigating CAR T-Cell Therapy for Non-Hodgkin Lymphoma in Community Practice]( [RECENT DEVELOPMENTS IN]( [Recent Developments in Seasonal Allergies]( [WASHINGTON WATCH]( [Emergency Medicine Doc Is Running for Congress]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [ASCO READING ROOM]( [Trying to Fill Need for More Nuanced, Patient-Centered SCLC Treatments]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [ASCO READING ROOM]( [Jennifer Litton, MD, on Defining Endpoints for Neoadjuvant Breast Cancer Trials]( [PSYCHIATRY]( [Giving Up Pets to Seek Rehab Can Worsen Trauma. A Group Intends to End That.]( [RHEUMATOLOGY]( [Arthritis Patients More Likely to Stick With Biosimilars]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [On the Frontline: Emergency Medicine's Role in Managing Bispecific Antibody Events in Multiple Myeloma]( [ONCOLOGY/HEMATOLOGY]( [BTK Inhibitor Active in Half of Patients With Richter Transformation]( [DERMATOLOGY]( [Young Girls Are Using Anti-Aging Products They See on TikTok. Experts Warn on Harms.]( [CARDIOLOGY]( [TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space]( CME SPOTLIGHT [Expert Strategies for Recognition and Management of Adverse Events of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma]( [PSYCHIATRY]( [New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk]( [PERSPECTIVES]( [The Widowmaker: Clarifying the Record for Our Patients]( [PULMONOLOGY]( [Novel Smart Mask Monitors Exhaled Breath Continuously]( CME SPOTLIGHT [Empowering Historically Underrepresented Patients: Overcoming Healthcare Disparities in Multiple Myeloma]( [MEETING COVERAGE]( [ESC Streamlines Cardiovascular Guidelines]( [ENDOCRINOLOGY]( [Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics]( [MEETING COVERAGE]( [Invasive Strategy for NSTEMI in the Elderly: Fears Don't Pan Out in SENIOR-RITA]( CME SPOTLIGHT [Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy]( [NEUROLOGY]( [Brain Clock Disparities; How Morphine Relieves Pain; Tolebrutinib and MS Disability]( [INFECTIOUS DISEASE]( [FDA OKs Updated Novavax COVID Shot]( [MEETING COVERAGE]( [Oral Anticoagulation and TAVR Together: A Recipe for Trouble]( # Weekly Survey [Should Candidates' Medical Records Be Public?]( Vice President Kamala Harris, the Democratic presidential nominee, has [not publicly released her medical history]( and there is no legal requirement for her to do so.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-09-03&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.